-- 
Al Khodari Sons, Saudi Pharmaceuticals: Saudi Equity Preview

-- B y   M o u r a d   H a r o u t u n i a n
-- 
2011-06-18T07:10:23Z

-- http://www.bloomberg.com/news/2011-06-18/al-khodari-sons-saudi-pharmaceuticals-saudi-equity-preview.html
The following stocks may rise or
fall in Saudi Arabiaâ€™s market. Stock symbols are in parentheses
and prices are from the last close.  The  Tadawul All Share Index (SASEIDX)  declined 0.3 percent to
6,546.06 on June 15.  Abdullah A.M. Al-Khodari Sons Co. (ALKHODAR)  : The Saudi
Arabian contractor signed two contracts valued at 178.6 million
riyals ($48 million) with the Ministry of Municipal and Rural
Affairs. A 112.4 million-riyal contract is for road
infrastructure in Taif and a 66.2 million-riyal contract is for
work on a road intersection in Asir. The shares dropped 2.4
percent to 70.25 riyals.  Saudi Pharmaceutical Industries and Medical Appliances
Corp. (SPIMACO AB): The company known as Spimaco said will raise
its stake in its unit, CAD  Middle East  for Pharmaceutical
Industries to 40 percent from 25 percent. It will also grant the
unit an interest-free loan valued at 40.7 million riyals.
Spimaco also said it will own a 40 percent stake in a $12
million joint venture with Cooper Pharma of  Morocco . The shares
dropped 0.3 percent to 38.20 riyals.  To contact the reporters on this story:
Mourad Haroutunian in Riyadh at 
 mharoutunian@bloomberg.net .  To contact the editors responsible for this story:
Shaji Mathew at   shajimathew@bloomberg.net  